• Home
  • About
  • Press
  • Services
  • Legal
  • Payment
  • Contact
  • Facebook
  • Twitter
The Wall Street Analyzer

  • Featured Interviews
  • CEO Interviews
  • News Feed
  • Spotlight
  • Sectors
    • Biotech
    • Cannabis
    • Consumer
    • Energy
    • Healthcare
    • Market News
    • Technology
Latest News
  • [ January 26, 2023 ] SCOTTIE RESOURCES INTERCEPTS 34.5 G/T GOLD OVER 4.7 METRES ON BLUEBERRY CONTACT ZONE News Feed
  • [ January 24, 2023 ] Zomedica to Participate in the Lytham Partners Investor Select Conference News Feed
  • [ January 23, 2023 ] XORTX Announces Positive Topline Results from XRX-OXY-101 Clinical Trial News Feed
  • [ January 18, 2023 ] Zomedica to Take Control of New Assay Development and Manufacturing of TRUFORMA Product Line through Long-Term Licensing Agreement with Qorvo Biotechnologies News Feed
  • [ January 17, 2023 ] SCOTTIE RESOURCES ANNOUNCES BOARD APPOINTMENT OF ELLIE OWENS News Feed
  • [ January 12, 2023 ] SCOTTIE RESOURCES INTERCEPTS 8.21 G/T GOLD OVER 19 METRES ON BLUEBERRY CONTACT ZONE News Feed
  • [ January 12, 2023 ] Zerify Forecasts Strong Revenues & Increased Growth for 2023 News Feed
HomeCEO Interviews

CEO Interviews

CEO Interviews

DESERT MOUNTAIN ENERGY CORP. (TSX.V: DME) (U.S. OTC: DMEHF)(Frankfurt: QM01)

January 26, 2023 The Wall Street Analyzer 0
CEO Interviews

Humacyte (NASDAQ: HUMA)

January 19, 2023 The Wall Street Analyzer 0

ABOUT: Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and complex tissue and organ systems designed to improve the lives of patients and transform the practice […]

CEO Interviews

GeoVax Labs (NASDAQ: GOVX)

January 17, 2023 The Wall Street Analyzer 0

ABOUT: GeoVax Labs, Inc. is a clinical-stage biotechnology company developing novel therapies and vaccines for cancers and many of the world’s most threatening infectious diseases. The company’s lead program in oncology is a novel oncolytic […]

CEO Interviews

Tribal Rides International Corp. (OTC PINK: XNDA)

January 17, 2023 The Wall Street Analyzer 0

Interview with Joseph Grimes, CEO
[…]

CEO Interviews

PaperClip, Inc (OTC: PCPJ)

January 16, 2023 The Wall Street Analyzer 0

Interview with Mike Bridges, President and COO & Chad Walter, Chief Revenue Officer […]

CEO Interviews

Renewable Innovations (OTC: REII)

January 16, 2023 The Wall Street Analyzer 0

Interview with Robert Mount, CEO and Lynn Barney, CFO […]

CEO Interviews

Canaquest Medical Corp (OTC: CANQF)

January 10, 2023 The Wall Street Analyzer 0

Interview update with Paul Ramsay, Co-Founder & President […]

CEO Interviews

Innovative Eyewear, Inc. (NASDAQ: LUCY)

January 6, 2023 The Wall Street Analyzer 0

Interview with Harrison Gross, CEO and Co-Founder […]

CEO Interviews

OpenLocker Holdings (OTCQB: OLKR)

December 19, 2022 The Wall Street Analyzer 0

THIS INTERVIEW HAS EXPIRED< PLEASE CHECK OUT OUR FEATURED INTERVIEW SECTION FOR OTHER EXCITING OPPORTUNITIES

CEO Interviews

Predictive Oncology (NASDAQ: POAI)

December 13, 2022 The Wall Street Analyzer 0

ABOUT: Predictive Oncology (NASDAQ: POAI) is a knowledge-driven company focused on applying artificial intelligence (AI) to develop optimal cancer therapies, which can ultimately lead to more effective treatments and improved patient outcomes. Through AI, Predictive Oncology uses […]

Posts navigation

1 2 … 64 »

Featured Companies

CEO Interviews

Zomedica Corp. (NYSE American: ZOM)

November 29, 2022 0

Interview update with Larry Heaton, CEO and President […]

CEO Interviews

Acutus Medical (NASDAQ: AFIB)

November 19, 2022 0

Interview with David Roman, CEO […]

Featured Interviews

Zerify (OTCQB: ZRFY)

November 18, 2022 0

Interview with Mark Kay, CEO and Chairman […]

Featured Interviews

Xortx Therapeutics (CSE: XRX) (NASDAQ: XRTF)

October 25, 2022 0

Interview update with Dr. Allen Davidoff, CEO
[…]

CEO Interviews

Pro-Dex, Inc (NASDAQ: PDEX) CEO Interview Update

October 24, 2022 0

Interview with Rick Van Kirk, CEO […]

News Wire

  • SCOTTIE RESOURCES INTERCEPTS 34.5 G/T GOLD OVER 4.7 METRES ON BLUEBERRY CONTACT ZONE
    January 26, 2023 0
  • Zomedica to Participate in the Lytham Partners Investor Select Conference
    January 24, 2023 0
  • XORTX Announces Positive Topline Results from XRX-OXY-101 Clinical Trial
    January 23, 2023 0
  • Zomedica to Take Control of New Assay Development and Manufacturing of TRUFORMA Product Line through Long-Term Licensing Agreement with Qorvo Biotechnologies
    January 18, 2023 0
  • SCOTTIE RESOURCES ANNOUNCES BOARD APPOINTMENT OF ELLIE OWENS
    January 17, 2023 0
  • SCOTTIE RESOURCES INTERCEPTS 8.21 G/T GOLD OVER 19 METRES ON BLUEBERRY CONTACT ZONE
    January 12, 2023 0
  • Zerify Forecasts Strong Revenues & Increased Growth for 2023
    January 12, 2023 0




Follow on Facebook

About Us

The Wall Street Analyzer's staff of writers, analysts, publishers, producers, market researchers, and PR professionals aim to provide investors with the tools they need to make informed decisions on buying stock. Our staff is a mix of financial professionals and media savvy individuals whose experiences bring the best talent from both ends of the spectrum.
Quick links
  • Home
  • About
  • Press
  • Services
  • Legal
  • Payment
  • Contact
Stay connected
  • Facebook
  • Twitter
Recent Case Study
Biotech

Co-Diagnostics (NASDAQ: CODX) is Well-positioned with 3 Key Verticals

August 12, 2019 Comments Off on Co-Diagnostics (NASDAQ: CODX) is Well-positioned with 3 Key Verticals

About Co-Diagnostics, Inc: Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company’s technology is utilized for tests that are designed using the detection […]

Testimonials
Testimonials

Client Testimonials:

June 1, 2020 Comments Off on Client Testimonials:

“What we like most about the wallstreetanalyzer.com was their service consistently brought Marifil Mines Ltd new viewers to our company.  The interviews are high quality, to the point, friendly and enlightening.  We have been using his […]

Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com